Immunomodulatory effects of CD38-targeting antibodies
Year: 2018
Type: review
Source: Immunology Letters
Author: Niels W.C.J. van de Donk
Institution: Amsterdam UMC Location Vrije Universiteit Amsterdam
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: daratumumab, multiple myeloma, immunomodulation, antibody-dependent cellular cytotoxicity, antibody-dependent cellular phagocytosis, complement-dependent cytotoxicity, regulatory T cells, regulatory B cells, myeloid-derived suppressor cells, adenosine, bone marrow microenvironment, lenalidomide, pomalidomide, PD-1/PD-L1 inhibitors, combination therapy
Open Access status: closed
Funders: Amgen, Novartis, Celgene, Janssen Pharmaceuticals
OpenAlex ID: W2799533550
